This should be no surprise given the recent Indevus acquisition (gotta streamline, right?), but Endo Pharmaceuticals has axed over 100 employees from both sides of the deal with the majority coming from Endo. A tipster wrote us that the layoffs happened early last week although specific departments or product division details weren’t given.

Endo is set to announce its first quarter financial results on April 29th so perhaps CEO David Holveck might give some details then.

Until then, it’s a waiting game because it’s just a rumor guys.

Nevertheless, the bloodbath goes on…

Image from ampainsoc

Related Posts